Companies: 10,795·Total market cap: $144.5T
Sinopharm Group Co. Ltd.

Sinopharm Group Co. Ltd.

SHTDFOTCHealthcare● Active
$2.30
+$0.01(+0.44%)
Market Cap$7.2B
P/E Ratio
52W High$2.7
52W Low$2.11

Sinopharm Group Co. Ltd.(SHTDF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · SHTDF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$560.33B$584.51B$596.57B$552.15B$521.05B
Cost of Revenue$520.17B$540.25B$548.06B$504.71B$477.00B
Gross Profit$40.15B$44.26B$48.51B$47.43B$44.05B
Gross Margin %(computed)7.17%7.57%8.13%8.59%8.45%
Operating Expenses
R&D Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
G&A Expenses$0.00B$8.41B$8.68B$8.18B$7.76B
Total Operating Expenses$23.92B$28.07B$28.30B$26.83B$24.34B
Operating Income$16.24B$16.19B$20.21B$20.60B$19.71B
Operating Margin %(computed)2.90%2.77%3.39%3.73%3.78%
Interest Income$0.49B$0.62B$0.53B$0.54B$0.56B
Interest Expense$2.43B$2.73B$2.96B$3.52B$3.76B
Income Before Tax$14.42B$14.00B$19.51B$18.56B$17.00B
Income Tax Expense$3.86B$3.58B$4.50B$4.22B$3.94B
Net Income$6.97B$7.05B$9.05B$8.53B$7.76B
Net Margin %(computed)1.24%1.21%1.52%1.54%1.49%
Per Share & EBITDA
EPS (Basic)$2.24$2.26$2.90$2.73$2.49
Wtd Avg Shares3.12B3.12B3.12B3.12B3.11B
EBITDA$20.41B$20.17B$26.90B$26.25B$24.68B
EBITDA Margin %(computed)3.64%3.45%4.51%4.75%4.74%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · CNY · B

深入了解Sinopharm Group Co. Ltd.

关于Sinopharm Group Co. Ltd.(SHTDF)损益表

Sinopharm Group Co. Ltd.(SHTDF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,SHTDF实现营收$560.33B,毛利润$40.15B(毛利率7.17%),净利润$6.97B(净利率1.24%)。

常见问题

SHTDF · 4 问

Sinopharm Group Co. Ltd.(SHTDF)2025财年营收为$560.33B,同比down4.1%。

SHTDF revenueSHTDF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09